MedTrade launches Celox™ Rapid – the fastest acting battlefield haemostat
Press Release – Tuesday 25th June 2013
MedTrade Products Ltd, developers of a range of advanced wound care products, is delighted to announce the European launch of Celox™ Rapid. The fastest haemostat on the market, Celox™ Rapid has been developed with unique, patented technology, in response to the real needs of battlefield medics and represents the next stage in not only the development of the original Celox™, which is already standard issue for the UK military, but sets a new standard for haemostatic agents/control.
In combat scenarios, time is very much of the essence in cases of severe bleeding caused by gunshot wounds or explosions. The injured soldier has to be treated and evacuated from the scene as fast as possible; even a matter of minutes can be too long. Celox™ Rapid can control the most serious, life-threatening bleeding with just 60 seconds compression.
Easily carried in a slim-line pack, Celox™ Rapid comes in a strip of Z-fold gauze onto which Celox™ granules and Chito-R are bonded. The Chito-R, one of the distinguishing features of Celox™ Rapid, creates a unique adhesion (wet stick) to the source of the bleeding and works with the Chitosan already in the Celox™ to create a gel-like plug that stops the bleeding faster than any other treatment.
The Celox™ blood clotting technology was first developed by MedTrade precisely for the purpose of dealing with battlefield wounds and has been tried and tested in both Afghanistan and Iraq. Working independently of the body’s normal clotting processes, Celox™ generates no heat and does not burn the casualty or care giver. It has also been proven effective in situations where the blood does not clot normally, for example in cases of shock-induced hypothermia and in the presence of common anti-coagulants such as warfarin.
Chris Marsden, Head of Marketing for Celox said; “Speed is absolutely paramount in casualty care and Celox Rapid offers a radical change in the ability to deliver fast, effective treatment. Celox Rapid has had a great reception in the US and is already generating a huge amount of interest since its launch in Europe. We are very proud to support NATO troops and the emergency services with this new development.”
For further details and clinical reviews of Celox™ Rapid, please contact marketing@medtrade.co.uk
– Ends –
MedTrade Products Limited Press Office
Phone: +44 (0)844 822 1658
Mobile: +44 (0)7739 461 061
Email: abigail@singletonpr.com
Notes to Editors
For more information about the Celox™ range of products, please visit:
About MedTrade Products Ltd:
• MedTrade Products Ltd is an ethical, dynamic and fast growing medical device company, founded in 1999, and based in Crewe in the UK.
• The company has a strong record of developing and commercialising high quality wound care and related products for a range of clients and markets worldwide, including hospitals, the military and emergency services, veterinarians and the retail sector.
• All MedTrade products are made to the high standards of both ISO 13485 and FDA cGMP.
Social media:
Twitter – https://twitter.com/CeloxHaemostat
